ABOS Stock Price | Acumen Pharmaceuticals Inc P/E, Revenue, EPS, & Forecasts

Acumen Pharmaceuticals Inc • ABOS

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Acumen Pharmaceuticals Inc

Ticker

ABOS

Trading on

NASDAQ

ISIN

US00509G2093

Industry

Biotechnology

Sector

Healthcare

CEO

Daniel J. O'Connell M.B.A.

Headquarters

427 Park Street, Charlottesville, VA, United States, 22902

Employees

Website

https://acumenpharm.com

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Metrics

BasicAdvanced

Market cap

$71.5M

P/E ratio

EPS

-$1.38

Dividend Yield

0.00%

Beta

0.02

Forward P/E ratio

EBIDTA

$-92.8M

Ex dividend date

Price & volume

Market cap

$71.5M

Average daily volume

0.2M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

538.78

Price to book

0.33

Earnings

EPS

-$1.38

EPS estimate (current quarter)

-$0.36

EPS estimate (next quarter)

-$0.39

EBITDA

$-92.8M

Revenues (TTM)

$0.3M

Revenues per share (TTM)

$0.03

Technicals

Beta

0.02

52-week High

$4.28

52-week Low

$1.10

50-day moving average

$1.40

200-day moving average

$2.24

Short ratio

8.97

Short %

3.97%

Management effectiveness

ROE (TTM)

32.83%

ROA (TTM)

20.99%

Profit margin

0.00%

Gross profit margin

$-43.6M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

60.1M

Float

32.3M

Insiders %

11.24%

Institutions %

76.57%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 6 analysts.

Average price target

$10.80

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.28

-$0.26

7.69%

Q4 • 23Beat

-$0.25

-$0.26

3.85%

Q1 • 24Beat

-$0.34

-$0.28

21.43%

Q2 • 24Beat

-$0.50

-$0.36

37.61%

Q3 • 24Beat

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-20.5M

∞%

Q2 • 24

$0M

$-29.8M

∞%

Q3 • 24

NaN%

44.93%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$289M

$45M

15.56%

Q2 • 24

$267M

$49.8M

18.64%

Q3 • 24

7.59%

10.69%

19.79%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-16.5M

$37.7M

$-0.1M

$-16.6M

Q2 • 24

$-24.6M

$-10.1M

$-0M

$-24.6M

Q3 • 24

48.66%

126.88%

67.19%

48.62%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Acumen Pharmaceuticals Inc share?

Acumen Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Acumen Pharmaceuticals Inc have?

Acumen Pharmaceuticals Inc currently has 60.1M shares.

Does Acumen Pharmaceuticals Inc pay dividends?

No, Acumen Pharmaceuticals Inc doesn't pay dividends.

What is Acumen Pharmaceuticals Inc 52 week high?

Acumen Pharmaceuticals Inc 52 week high is $4.28.

What is Acumen Pharmaceuticals Inc 52 week low?

Acumen Pharmaceuticals Inc 52 week low is $1.10.

What is the 200-day moving average of Acumen Pharmaceuticals Inc?

Acumen Pharmaceuticals Inc 200-day moving average is $2.24.

Who is Acumen Pharmaceuticals Inc CEO?

The CEO of Acumen Pharmaceuticals Inc is Daniel J. O'Connell M.B.A..

How many employees Acumen Pharmaceuticals Inc has?

Acumen Pharmaceuticals Inc has 51 employees.

What is the market cap of Acumen Pharmaceuticals Inc?

The market cap of Acumen Pharmaceuticals Inc is $71.5M.

What is the P/E of Acumen Pharmaceuticals Inc?

The current P/E of Acumen Pharmaceuticals Inc is null.

What is the EPS of Acumen Pharmaceuticals Inc?

The EPS of Acumen Pharmaceuticals Inc is -$1.38.

What is the PEG Ratio of Acumen Pharmaceuticals Inc?

The PEG Ratio of Acumen Pharmaceuticals Inc is null.

What do analysts say about Acumen Pharmaceuticals Inc?

According to the analysts Acumen Pharmaceuticals Inc is considered a buy.